InsightfulValue
← Home

Takeda Pharmaceutical
Takeda Pharmaceutical

Pharma / Pharmaceuticals, Healthcare


Revenue Segmentation by Product

Switch to Location
Fiscal year Segment Value
2024 Elaprase 91.56B
2024 Adderall XR 41.76B
2024 Other Rare Hematology 47.3B
2024 Oncology 462.36B
Takeda Pharmaceutical

💰 Explore more revenue segmentation data for Takeda Pharmaceutical!

Sign up for free or log in
© 2024 - 2025 InsightfulValue.com. All rights reserved. Legal